# Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).

> **NCT00987129** · — · TERMINATED · sponsor: **Yves Sauve** · enrollment: 200 (actual)

## Conditions studied

- Age-related Macular Degeneration

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00987129
- **Lead sponsor:** Yves Sauve
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03
- **Primary completion:** 2014-03
- **Final completion:** 2014-12
- **Target enrollment:** 200 (ACTUAL)
- **Why stopped:** Insufficient recruitment
- **Last updated:** 2015-01-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00987129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00987129, "Omega 6:Omega 3 Ratio and Progression of Age-related Macular Degeneration (AMD).". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00987129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*